Goldman Sachs’s Tuscan Holdings Corp. II Common Stock THCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100,000
Closed -$1.02M 7105
2021
Q4
$1.02M Hold
100,000
﹤0.01% 4819
2021
Q3
$1.01M Hold
100,000
﹤0.01% 4729
2021
Q2
$1M Sell
100,000
-50,000
-33% -$502K ﹤0.01% 4753
2021
Q1
$1.51M Buy
+150,000
New +$1.6M ﹤0.01% 4268
2020
Q4
Sell
-19,200
Closed -$192K 5802
2020
Q3
$192K Sell
19,200
-249,800
-93% -$2.5M ﹤0.01% 4930
2020
Q2
$2.7M Buy
269,000
+254,000
+1,693% +$2.51M ﹤0.01% 3244
2020
Q1
$146K Buy
+15,000
New +$148K ﹤0.01% 4825

Other funds holding THCA

Goldman Sachs's THCA Position: Q1 2022 in Review

Goldman Sachs sold out of Tuscan Holdings Corp. II Common Stock (THCA) in Q1 2022, closing a stake of 100,000 shares — an estimated $1.02M sold.

Goldman Sachs first reported a position in THCA in Q1 2020 and held it in 7 quarters. The position peaked at $2.7M in Q2 2020. 21 funds tracked by Wall St. Rank hold THCA as of Q1 2022.

  • Goldman Sachs reported no remaining Tuscan Holdings Corp. II Common Stock position as of Q1 2022 after selling out during the quarter.
  • Goldman Sachs sold 100,000 Tuscan Holdings Corp. II Common Stock shares in Q1 2022, an estimated $1.02M.
  • Goldman Sachs first reported a position in Tuscan Holdings Corp. II Common Stock in Q1 2020 and held it in 7 quarters.
  • Goldman Sachs's Tuscan Holdings Corp. II Common Stock position peaked at $2.7M in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Tuscan Holdings Corp. II Common Stock as of Q1 2022.

Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.